Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-037190
Filing Date
2022-02-11
Accepted
2022-02-11 16:36:06
Documents
2
Group Members
COLUMN GROUP III GP, LPCOLUMN GROUP III-A, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G d312718dsc13g.htm SC 13G 70783
2 EXHIBIT 1 d312718dex991.htm EX-99.1 6727
  Complete submission text file 0001193125-22-037190.txt   79127
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP III, LP (Filed by) CIK: 0001668159 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Subject) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92757 | Film No.: 22621783
SIC: 2836 Biological Products, (No Diagnostic Substances)